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Both Mycoplasma hominis and Trichomonas vaginalis utilize arginine as an energy source via the
arginine dihydrolase (ADH) pathway. It has been previously demonstrated that M. hominis forms a
stable intracellular relationship with T. vaginalis; hence, in this study we examined the interaction
of two localized ADH pathways by comparing T. vaginalis strain SS22 with the laboratory-
generated T. vaginalis strain SS22-MOZ2 infected with M. hominis MOZ2. The presence of M.
hominis resulted in an approximately 16-fold increase in intracellular ornithine and a threefold
increase in putrescine, compared with control T. vaginalis cultures. No change in the activity of
enzymes of the ADH pathway could be demonstrated in SS22-MOZ2 compared with the parent
SS22, and the increased production of ornithine could be attributed to the presence of M.
hominis. Using metabolic flow analysis it was determined that the elasticity of enzymes of the ADH
pathway in SS22-MOZ2 was unchanged compared with the parent SS22; however, the elasticity
of ornithine decarboxylase (ODC) in SS22 was small, and it was doubled in SS22-MOZ2 cells.
The potential benefit of this relationship to both T. vaginalis and M. hominis is discussed.
INTRODUCTION
The arginine dihydrolase (ADH) pathway catalyses the
conversion of arginine to ornithine and ammonia via the
enzymes arginine deiminase (ADI), catabolic ornithine
carbamyltransferase (cOCT) and carbamate kinase (CK)
(Fig. 1). Cumulatively, the pathway removes nitrogen from
amino acids with the generation of ATP, performing a
function analogous to that of the urea cycle of vertebrates.
The ADH pathway is present in some protists such as
Trichomonas vaginalis (Linstead & Cranshaw, 1983) and
Giardia intestinalis (Schofield et al., 1990), as well as some
Gram-positive (Streptococcus spp.; Griswold et al., 2004) and
Gram-negative bacteria (Pseudomonas spp.; Lu et al., 2004),
and some Mollicutes (Mycoplasma hominis, Mycoplasma
arginini; Fenske & Kenny, 1976; Das et al., 2004), in which it
has been proposed to function as an alternative ATP-
generating mechanism. The Giardia lamblia ADI is pro-
posed to have multiple functions, including a peptidylargi-
nine deiminase that converts protein bound arginine to
citrulline (Touz et al., 2008). No such activity has been
demonstrated for T. vaginalis, in which the pathway is
proposed to function solely for energy generation, contrib-
uting about 10% of the total energy requirements (Yarlett
et al., 1996). In T. vaginalis, the first and rate-limiting
enzyme, ADI, is localized to a subcellular fraction, possibly
the hydrogenosome, whereas the other enzymes of the
pathwayarepresentinthecytoplasmicfraction(Yarlettetal.,
1994).
T. vaginalis and several Mycoplasma species (M. hominis,
Mycoplasma genitalium, Ureaplasma urealyticum) are
common urogenital parasites of vertebrates. In addition,
M. hominis is commonly found as an intracellular parasite
of T. vaginalis (Rappelli et al., 1998; Dessı ` et al., 2005), but
not of Tritrichomonas foetus (Dessı ` et al., 2005). In a study
of 35 patients with trichomoniasis, M. hominis was isolated
from 33 patients by in vitro culture of T. vaginalis; no other
Mycoplasma species was detected (Dessı ` et al., 2005). The
exact nature of this intimate relationship between T.
vaginalis and M. hominis is unknown, but it has been
proposed to be saprophytic (Rappelli et al., 1998). This
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3734 042192 G 2010 SGM Printed in Great Britainstudy attempts to clarify the metabolism of arginine in T.
vaginalis infected with M. hominis, and to determine
whether this relationship benefits T. vaginalis and/or M.
hominis.
METHODS
Cultures. T. vaginalis SS22, T. vaginalis infected with M. hominis
(SS22-MOZ2) and M. hominis (MOZ2) were cultured in tryptose–
yeast extract–maltose medium supplemented with 10% horse serum
(Diamond, 1957). The presence of M. hominis in T. vaginalis SS22-
MOZ2 was detected by PCR using the primers RNAH1 and RNAH2
for M. hominis (Blanchard et al., 1993), as previously described
(Rappelli et al., 1998). The isogenic strain SS22-MOZ2 was obtained
by infecting SS22 with M. hominis (MOZ2) isolated from a naturally
occurring T. vaginalis strain, MPM-02, infected with M. hominis.
Briefly, T. vaginalis MPM-02 was harvested during exponential
growth by centrifugation at 350 g, and the supernatant was filtered
through a 0.45 mm pore-size filter membrane. An aliquot of filtered
supernatant containing 10
6 (calculated as c.f.u.) mycoplasma was
added to a 10 ml culture of T. vaginalis SS22. Identical bacterial
suspensions were inoculated both on 10 ml fresh Diamond’s medium
(Diamond, 1957) and on 10 ml T. vaginalis-conditioned medium
(obtained from a filtered overnight culture of mycoplasma-free SS22).
All samples were then daily passaged with 1:16 dilution for 30 days.
Exponential-phase cells were harvested at 4000 g for 10 min at 4 uCi n
a Sorvall RC-2B centrifuge (DuPont) and washed in a buffer
containing 30 mM sodium phosphate, 74 mM sodium chloride,
0.6 mM calcium chloride and 1.6 mM potassium chloride, pH 7.4.
Washed cells were resuspended in 225 mM sucrose–10 mM Tris
isotonic buffer, pH 7.4.
Subcellular fractionation. Concentrated cell pellets were broken by
35 strokes in a Potter–Elvehjem tissue homogenizer at 4 uC. The
broken cells were diluted with 225 mM sucrose–10 mM Tris, pH 7.4,
containing 1 mM calcium chloride and 1 mM magnesium chloride,
and centrifuged successively at 400 g for 10 min, 2200 g for 10 min
and 28000 g for 30 min, yielding nuclear-enriched, hydrogenosome-
enriched and lysosome-enriched pellets, respectively.
Density-gradient centrifugation. Self-generating gradients were
prepared using 50% (w/v) Percoll containing 225 mM sucrose–
10 mM Tris, pH 7.4, 1 mM calcium chloride and 1 mM magnesium
chloride. Fractions (1 ml, 12–18 mg protein) were layered onto 10 ml
Percoll mixture and centrifuged at 46000 g for 45 min at 4 uCi na
6612 ml swing-out rotor (Beckman OTD 95). Fractions were
Fig. 1. Enzymes of the ADH pathway. Enzyme reactions that occur in the hydrogenosome are indicated in the lower box;
enzyme reactions that occur in the intracellular M. hominis are indicated in the upper box. M. hominis and T. vaginalis enzymes
are prefixed Mh and Tv, respectively.
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calculated from determining the weight of 1 ml volumes. Chemicals
and reagents were supplied by Sigma.
For enzyme analysis, T. vaginalis SS22, SS22-MOZ2 and M. hominis
MOZ2 were cultured as described above in 1 l of medium. Cells were
harvested by centrifugation at 5000 g for 10 min, washed twice in PBS,
and resuspended in 10 mM phosphate buffer, pH 7.4, containing 1 mg
each of aprotinin, leupeptin and N-a-tosyl-L-lysinyl-chloromethylke-
tone (TLCK) ml
21. Cells were stored at 270 uC until used.
Enzyme assays. The integrity of the organelles was confirmed by
performing all enzyme assays in isotonic buffered solutions (225 mM
sucrose), to which 0.05% Triton X-100 was added to demonstrate
latency of activity. ADI (EC 3.5.3.6) was determined by measuring the
colorimetric formation of citrulline at 37 uC. The assay contained 0.5–
2.5 mM L-arginine, 40 mM MES, pH 8.0, and 0.07 mg protein in a
final volume of 1.0 ml. After 30 min, the reaction was stopped by the
addition of 0.075 ml 100% (w/v) TCA, and the citrulline formed
determined using diacetyl monoxime, as described by Boyde &
Rahmatullah (1980). cOCT (EC 2.1.3.3) was determined by measuring
14CO2 release from L-[
14C-carbamyl] citrulline. The reaction mixture
contained 40 mM Tricine, pH 6.0, 0.1 mM L-citrulline, 0.1–1.0 mM L-
[
14C-carbamyl] citrulline [57.7 mCi mmol
21 (2135 MBq mmol
21)]
(DuPont, N.E.N. Research Products) and 0.07 mg protein in a final
volume of 1 ml. After incubation at 37 uC for 1 h, the reaction was
stopped with 1 ml 40% TCA and incubated for a further 30 min, and
the CO2 was trapped using benzethonium hydroxide-soaked filter
paper. In the anabolic direction, anabolic ornithine carbamyltransfer-
ase (aOCT) was determined by measuring citrulline formation with
10 mM ornithine in 0.1 M Tris buffer, pH 8.0, and 0.07 mg protein;
the reaction was started by the addition of 10 mM carbamyl phosphate
and incubated for 15 min at 37 uC. The reaction was stopped by the
addition of 6% TCA, and the amount of citrulline formed was
determined as described by Boyde & Rahmatullah (1980). CK (EC
2.7.2.2) activity was determined in incubations containing 0.1–1.0 mM
ADP, 20 mM MgSO4, 0.15 mM luciferin, 1 mg firefly lantern extract
and 1 mM carbamyl phosphate, in 50 mM potassium phosphate
buffer, pH 7.6. ATP formation was determined by monitoring
luminescence using a photomultiplier tube. Ornithine decarboxylase
(ODC; EC 4.1.1.17) was determined by measuring the release of
14CO2
from 0.05–1.0 mM 1-[
14C]ornithine [42.5 mCi mmol
21 (1602.25 MBq
mmol
21)] in 0.1 M acetate buffer, pH 6.5, containing 60 mM pyridoxal
phosphate, as previously described (Yarlett et al., 1993). Malic enzyme
(EC 1.1.1.39) was assayed using 6 mM triethanolamine, pH 6.8,
containing 1 mM NAD, 0.66 mM MnCl2 and 0.1% Triton X-100; the
changeat A340 wasmonitored upon the addition of33 mM neutralized
sodium malate (Dolezal et al., 2004). Determination of the pH optima
of enzyme activities was performed using the above assay methods with
pHs varying from 5.0 to 7.5 with 40 mM MES (pKa 6.15 at 20 uC) and
from 7.0 to 9.0 with 40 mM HEPPS (pKa 8.0 at 20 uC). Protein
concentrations were determined using the Lowry method.
HPLC. The intracellular and extracellular amine content of T.
vaginalis SS22, SS22-MOZ2 and M. hominis MOZ2 was determined
by centrifugation of 24 h cultures at 5000 g for 10 min. Pellets were
washed once with PBS, pH 7.4, and proteins removed by addition of
6% TCA. Culture medium was mixed with 10% (v/v) of 60% TCA.
Samples were microfuged at 14000 g for 1 min, and amines were
separated by reverse-phase HPLC using a series LC 410 pump
(Perkin–Elmer) coupled to a C-18 10 mm particle size column
(4.56250 mm) at a flow rate of 1 ml min
21. The method employed a
70 min discontinuous gradient starting with 90% (v/v) buffer A:
0.1 M sodium phosphate monobasic, pH 2.65, containing 8 mM
octane sulfonic acid and 0.05 mM EDTA. Buffer B consisted of HPLC
grade acetonitrile. Separation of amines used a 35 min discontinuous
gradient switching to 80% A at 15 min and 60% A at 25 min,
followed by a 10 min recycle time to regenerate the start conditions.
Standards and samples were post-column derivatized by mixing with
two parts 1.5 mM o-phthalaldehyde dissolved in 3 ml methanol and
made up to 1 l with 0.5 M boric acid containing 0.43 M KOH and
0.014 M 2-mercaptoethanol, pH 10.4. The derivatized compounds
were analysed using a fluorescence monitor (lexcit 320 nm, lem
455 nm). Areas under the peaks were determined using b-RAM
computer software (IN/US Systems), version 1.62.
Enzyme kinetics. Kinetic analysis of the ADH pathway in T. vaginalis
SS22, SS22-MOZ2 and M. hominis MOZ2 was performed by varying
the substrate for each enzyme and measuring the rate of product
formation. Km and Vmax values were determined from straight-line
Hanes–Woolf plots ([S]/v versus [S]). The specificity constant V/Km is
derived from the initial slope of the graph of velocity versus substrate
concentration for a reaction that obeys the Michaelis–Menten equation
(Cornish-Bowden, 2004). This constant is therefore the second-order
rate constant for the reaction at low substrate concentration, which is
typically true for intracellular environments where substrate concen-
trations are below the Km concentration. The elasticity (e), which is
defined as the fractional change in rate of the enzyme for a fractional
change in substrate concentration, was determined for each enzyme in
the pathway from a plot of log(n) versus log[S] (Fell, 1997). The
intracellular concentration around which the elasticity was required
was determined by HPLC of the intracellular amine concentration and
the n at this substrate concentration determined from the Hanes–
Woolf plot. The enzyme elasticity was calculated from the slope of the
double log plot ranging from 95% of [S] to 105% of [S]. Using the
connectivity theorem (C
J
enz1.eenz1
s1 zC
J
enz2.eenz2
s2 ~0), it is possible to
express the ratio of the flux control coefficients for pairs of enzymes in
the pathway under different conditions (C
J
enz1=C
J
enz2~eenz2
s2 =eenz1
s1 ).
Bioinformatic analyses. The amino acid sequence of G. intestinalis
(strain WB) ADI (accession no. XP_001705755) was used as the query
for a BLAST search in the T. vaginalis (strain G3) genome database of
Eukaryotic Pathogen Database Resources (http://eupathdb.org/
eupathdb/). Threesequenceswith significantsimilarity toG. intestinalis
ADI (TVAG_467820, TVAG_344520 and TVAG_183850) were aligned
with M. hominis (accession no. D13314 0.1) and M. arginini (accession
no.CAA38210) using CLUSTAL_X (Thompsonet al., 1997)andmanually
edited with BioEdit software (Hall, 1999). Putative mitochondrial
targeting sequences and cellular localization were predicted using the
program PSORT II (http://psort.hgc.jp/).
Quantitative RT-PCR (RT-qPCR) of ADI. To determine whether the
elevated ADI activity in T. vaginalis SS22-MOZ2 compared with the
parent SS22 was related to the additive effect of intracellular M.
hominis or to upregulation of expression of T. vaginalis ADI, an RT-
qPCR was designed to compare the mRNA expression of all three
ADIs identified in the T. vaginalis genomic library. The three sets of
primers were designed on the basis of sequence differences between
M. hominis and T. vaginalis ADI. In particular, we used the following
pairs of primers: TvADI 423-cDNA-92185, Tv92185F (59-TTCGT-
CCAACCTTCAACTCAAGAAG-39) and Tv92185R (59-CTTTATC-
TGGATCTGGTGGTTTTTCATAG-39), amplicon length 111 bp;
TvADI-485-cDNA-96423, Tv96423F (59-CGCGCATCATCAAGTTT-
TCGC-39) and Tv96423R (59-CTTTTTGGGATTCGGTGGGTGC-
39), amplicon length 119 bp; TvADI-185-cDNA-86485, Tv86485F
(59-GCTCTGTTCAATTCAACGCAG-39) and Tv86485R (59-GAATT-
GTGTGGCAGCTGTTGGTGG-39), amplicon length 82 bp. These
sequences were used to probe the M. hominis-infected (SS22-MOZ2)
and -uninfected (SS22) strains of T. vaginalis. Results were compared
with the expression of the actin gene (housekeeping gene) in M.
hominis-infected and -uninfected T. vaginalis. RNA from cells was
harvested by centrifugation and extracted with TRIzol reagent (Invitro-
gen), followed by double DNase I digestion for subsequent RT-qPCR
with specific primers. Relative gene expression was calculated by the
M. Morada and others
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2DDCtmethod,byusingactinashousekeepinggene. Experimentswere
performed in triplicate, and variation in gene expression wasquantified
by calculating 2
2DDCt M. hominis-infected T. vaginalis/2
2DDCt:M.
hominis-uninfected T. vaginalis ratios. The expression of all ADI genes
was evaluated in triplicate in three different experiments.
RESULTS
Enzyme activities and metabolic flow through the
ADH pathway of T. vaginalis with and without M.
hominis
We have previously observed significant variations in the
activities of the ADH enzymes, particularly ADI and cOCT,
between different strains of T. vaginalis, and that was borne
out by the variations in enzyme activities observed for strain
SS22 in this study and by earlier data with strain C1 (Table 1
and Supplementary Table S1). The parent mycoplasma-free
T. vaginalis strain (SS22) was infected in vitro with M.
hominis (MOZ2), isolated from a naturally occurring T.
vaginalis isolate, MPM02, infected with M. hominis (MOZ2)
(Dessı ` et al., 2005). Typically, about 5–10 mycoplasma were
observed in these strains (Fig. 2). Whole-cell extracts
prepared from T. vaginalis SS22, T. vaginalis infected with
M. hominis SS22-MOZ2 and M. hominis MOZ2 were
examined for the kinetic properties of the enzymes of the
ADH pathway. The enzymes ornithine carbamyltransferase
(OCT), CK and ODC demonstrated minimal differences in
kinetic properties between T. vaginalis infected with M.
hominis SS22-MOZ2 and the parent uninfected T. vaginalis
SS22 (Table 1). In contrast, the first and rate-limiting
enzyme of the ADH pathway, ADI, demonstrated significant
differences in Vmax (Table 1). The T. vaginalis infected with
M. hominis SS22-MOZ2 had an average sixfold increased
Vmax compared with the uninfected parent SS22 (Table 1).
Overall, the T. vaginalis strain SS22-MOZ2 had a 19-fold
increased specificity (Vmax/Km) for ADI compared with the
parent strain SS22. The kinetic constants for ADI of M.
hominis (MOZ2) indicated that the Vmax and Km for ADI
were similar to those obtained for T. vaginalis strain SS22-
MOZ2, suggesting that the increased specificity for this
enzyme was the result of the presence of M. hominis. Kinetic
analysis of ADH enzymes from M. hominis revealed that the
specificity of ADI was 23-fold greater than that for T.
vaginalis SS22; likewise, kinetic analysis of cOCT revealed a
227-fold greater specificity than that of T. vaginalis strain
SS22 (Table 1); however, the ATP-forming enzyme CK was
fivefold more efficient in T. vaginalis SS22 compared with
M. hominis (Table 1). The combination of both ADH
pathways in T. vaginalis SS22-MOZ2 had a higher overall
specificity for conversion of arginine to ATP and ornithine,
which may be beneficial to T. vaginalis and M. hominis. The
elasticity (e) of the enzymes of the pathway was determined
using metabolic flow analysis (Fell, 1997). The only enzyme
ofthepathway withincreasedspecificitywasODC(Table2).
The pH optima of the enzymes from T. vaginalis SS22 and
SS22-MOZ2 were compared with those of M. hominis
(Supplementary Fig. S1). The optimum pH for cOCT was
6.0 for SS22, SS22-MOZ2 and MOZ2; however, aOCT was
found to have an optimal pH of 7.0 for MOZ2 and 8.0 for
T. vaginalis SS-22 and SS22-MOZ2. By comparison, ADI
was found to have an optimal pH of 6.5 for M. hominis
MOZ2 and T. vaginalis SS22-MOZ2, whereas the parent
uninfected T. vaginalis SS22 had an optimal pH of 8.0 for
ADI, further supporting the view that the M. hominis ADI
is responsible for the enhanced ADI kinetics in T. vaginalis
SS22-MOZ2.
ADI-coding genes and localization of the gene
products in T. vaginalis
A BLAST search of the T. vaginalis genome database revealed
the presence of three copies of the ADI gene (TvADI-1,
TvADI-2 and TvADI-3) encoding proteins with a calcu-
lated molecular mass of 46000–47000 Da. Alignment with
M. arginini, for which a crystal structure has been
determined (Das et al., 2004), revealed the presence of
conserved residues involved in substrate binding and/or
the enzyme active site (Fig. 3). The positional equivalent of
the catalytic triad Cys397, His268, Glu213 determined in
M. arginini ADI (Das et al., 2004) is conserved in TvADI-1
Table 1. Kinetic properties of ADH enzymes in the parent T. vaginalis SS22, T. vaginalis infected with M. hominis (SS22-MOZ2) and
M. hominis MOZ2
Enzyme assays were performed as described in Methods using whole-cell extracts. Vmax is expressed as mM min
21 using 1 mg protein. The Vmax and
Km values are expressed as mean±SD for four determinations. ND, Not detected.
Enzyme T. vaginalis SS22 T. vaginalis SS22-MOZ2 M. hominis
Vmax
(mM min
”1)
Km (mM) Vmax/Km Vmax
(mM min
”1)
Km (mM) Vmax/Km Vmax
(mM min
”1)
Km (mM) Vmax/Km
ADI 76.6±7.4 200±36 0.38 433±14.0 60±10 7.2 516±24 60±7.1 8.6
cOCT 40.1±4.5 138±18 0.29 48.0±12.1 125±23 0.38 11864±432 180±12 65.9
aOCT 1938±210 3400±170 0.57 1624±180 2900±240 0.56 75964±9258 4200±295 18.1
CK 3900±480 60±3.8 65.0 4274±390. 83±12.0 51.5 1274±94 95±12 13.4
ODC 1.10±0.2 18±3.0 0.06 1.15±0.3 16±2.0 0.07 ND ND –
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Glu228), while Cys405 is replaced by Ser405 in TvADI-3.
All three putative TvADI sequences contained a mitochon-
drion-like N-terminal targeting presequence with a pre-
dicted cleavage site for a processing peptidase (Fig. 3), and
a high probability of mitochondrial localization estimated
by PSORT II (56–65%) and TargetP (mTP values 0.500–
0.710). These predictions suggested the localization of ADI
in T. vaginalis hydrogenosomes, an anaerobic form of
mitochondria in these parasites. The T. vaginalis ADI
sequences group within the Eukaryota, suggesting that the
ADI-encoding genes were present in a common ancestor,
which does not support horizontal gene transfer from a
prokaryotic source (Supplementary Fig. S2).
Kinetics of ADI in hydrogenosomal fractions from
M. hominis-infected and -uninfected T. vaginalis
Subcellular fractionation of T. vaginalis SS22 and the M.
hominis-infected SS22-MOZ2 had typical distribution
profiles for hydrogenosomes based upon the data for malic
enzyme, a marker enzyme for the organelle (Fig. 4a, b). The
relative specific activity plot for ADI mirrored that for
malic enzyme in extracts prepared from SS22 (Fig. 4c).
However, the SS22-MOZ2 fractions typically had a second
band of ADI activity which co-sedimented with the nuclear
fraction, suggesting that M. hominis sediments with the
nuclei and only minor contamination of the hydrogeno-
some fraction occurred (Fig. 4d). OCT, which in aerobic
eukaryotes localizes to the mitochondrion, was found
predominantly in the non-sedimentable fraction in both
SS22 and SS22-MOZ2 (Fig. 4e, f). Kinetic analysis of ADI
using the hydrogenosome-enriched fractions from T.
vaginalis SS22 and SS22-MOZ2 revealed minimal differ-
ences in the Vmax (65.8±1.2 and 79.8±2.8 mM min
21,
respectively) and Km (180±16 and 187±8.4 mM, respect-
ively), suggesting that the observed increase in ADI kinetics
for whole-cell studies of M. hominis-infected T. vaginalis
was due to the contribution of M. hominis and not
overexpression of host cell ADI. Further purification of
hydrogenosome-enriched fractions by Percoll gradients
revealed a single fraction with maximum ADI activity from
SS22 and an isopycnic density of 1.23 g ml
21 (Fig. 5a),
which overlays malic enzyme, a marker for hydrogeno-
somes (Fig. 5c). When the hydrogenosome-enriched
fraction obtained from SS22-MOZ2 was used, the Percoll
gradient purification resulted in two fractions with ADI
activity, the hydrogenosomal fraction at 1.24 g ml
21 and a
second fraction at 1.27 g ml
21 (Fig. 5b). The activity in the
1.27 g ml
21 fraction overlaid M. hominis ADI (Fig. 5d).
Intracellular and extracellular amine
concentrations from T. vaginalis SS22 and SS22-
MOZ2 cultures
The intracellular and extracellular concentrations of amines
associated withthe ADH pathwayweredeterminedbyHPLC
analysis of acid extracts. The intracellular concentration of
arginine was not significantly different in the two strains
(Table 3). However, arginine utilization was approximately
2.5-fold increased in T. vaginalis (SS22-MOZ2) cultures
infected with M. hominis (Table 3). The increased flow
through the ADH pathway of T. vaginalis SS22-MOZ2 was
reflected by the increased intracellular ornithine concentra-
tion, which was 15-fold higher in SS22-MOZ2 than in the
Fig. 2. M. hominis in experimentally infected T.
vaginalis strain SS22-MOZ 2. M. hominis was
visualized by DNA stainingusing 49,6-diamidino-
2-phenylindole (DAPI; blue). Hydrogenosomes
were stained for malic enzyme using rabbit poly-
clonal anti-malic enzyme antibody and Alexa
Fluor 546-conjugated donkey anti-rabbit immu-
noglobulin (red). Bar, 10 mm.
Table 2. Flux control coefficients for enzymes of the ADH pathway in T. vaginalis strain SS22 and T. vaginalis infected with M.
hominis (SS22-MOZ2)
Enzyme elasticities and flux control coefficients are expressed as e
Enzyme
substrate and C
J
Enzyme, respectively.
T. vaginalis strain eADI
arg eOCT
cit eODC
orn C
J
ADI=C
J
OCT C
J
ADI=C
J
ODC
SS22 1.07 1.01 0.04 0.94 0.035
SS22-MOZ2 1.00 0.98 0.09 0.98 0.10
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3738 Microbiology 156Fig. 3. Genome sequence of ADI from T. vaginalis. Sequences were obtained by BLAST search in the T. vaginalis genome database (strain G3) of Eukaryotic Pathogen
Database Resources (http://eupathdb.org/eupathdb/) using G. intestinalis (strain WB) ADI (accession no. XP_001705755) as query. Three sequences with significant
similarity to G. intestinalis ADI (TVAG_467820, TVAG_344520 and TVAG_183850) were aligned with M. hominis (accession no. D13314 0.1) and M. arginini (accession no.
CAA38210) using CLUSTAL_X (Thompson et al., 1997) and manually edited with BioEdit software (Hall, 1999). Putative mitochondrial targeting sequences (underlined) were
predicted using the program PSORT II (http://psort.hgc.jp/). Triangles indicate residues involved in substrate binding and reaction mechanism (Das et al., 2004). Asterisk, fully
conserved residue; colon, ‘strong’ group; period, conserved ‘weaker’ group according to CLUSTAL X.
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9parent strain SS22 (Table 3). A similar fivefold increase was
observed for the extracellular ornithine concentration. Also,
intracellular and extracellular putrescine had approximately
twofoldhigherintracellularandthreefoldhigherextracellular
concentrations in SS22-MOZ2 compared with the parent
SS22. A duplicate set of data were obtained using the T.
vaginalis C1/C1-MOZ2 pair (Supplementary Table S2).
RT-qPCR ADI in M. hominis-infected and
-uninfected T. vaginalis
The ratio of mRNA expression levels for ADI in SS22-
MOZ2/SS22 (2
2DDCt infected T. vaginalis/2
2DDCt uninfec-
ted T. vaginalis) was 0.69 (TvADI-1), 0.6 (TvADI-2) and
1.29 (TvADI-3). These results indicate that TvADI-1 and
TvADI-2 are 30% downregulated, while TvADI-3 is 30%
upregulated in mycoplasma-infected trichomonads. Since a
30% difference in mRNA expression, as evaluated by real-
time RT-qPCR, is considered minor, it is concluded that an
absence of upregulation or downregulation of the overall
TvADI expression occurs in T. vaginalis cells infected with
M. hominis.
DISCUSSION
ADI is the first step in the most widespread anaerobic route
of arginine degradation via the ADH pathway. The
pathway provides an important source of energy genera-
tion from amino acids in the absence of oxygen in some
protists (Schofield et al., 1990; Yarlett et al., 1996), and T.
Fig. 4. Subcellular localization of ADH enzymes in T. vaginalis SS22, T. vaginalis infected with M. hominis (SS22-MOZ2) and
M. hominis MOZ2. Distribution and percentage recovery for each enzyme after subcellular fractionation of T. vaginalis (a) SS22
malic enzyme, 93%; (b) SS22-MOZ2 malic enzyme, 88%; (c) SS22 ADI, 87%; (d) SS22-MOZ2 ADI, 96%; (e) SS22 cOCT,
98%; and (f) SS22-MOZ2 cOCT, 104%.
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this pathway (Yarlett et al., 1996). The ADH pathway is also
present in M. hominis (Fenske & Kenny, 1976), a member of
the Mollicutes, which has a symbiotic relationship with T.
vaginalis (Dessı ` et al., 2005). Consequently, T. vaginalis
infected with M. hominis contains two localized pathways
competing for the same substrate, arginine. The effect of this
endosymbiotic relationship on the ADH pathway of T.
vaginalis has not previously been examined. We showed that
cultures of T. vaginalis infected with M. hominis exhibit
Fig. 5. Isopycnic density-gradient centrifugation of the hydrogenosome-enriched fractions. Hydrogenosome-enriched fractions
from T. vaginalis SS22, T. vaginalis infected with M. hominis SS22-MOZ2 and M. hominis MOZ2 obtained by differential
centrifugation were purified using Percoll gradients. Fractions were assayed for ADI and malic enzyme as described in Methods.
(a) Distribution of ADI in SS22 revealed a major peak of activity at a density of 1.23 g ml
”1; (b) SS22-MOZ2 had two peaks of
activity at densities of 1.23 and 1.27 g ml
”1 for ADI; (c) SS22 had a single major peak of activity at 1.23 g ml
”1 for the
hydrogenosome marker enzyme malic enzyme; (d) MOZ2 had a single peak of activity for ADI at a density of 1.27 g ml
”1.
Percentage recoveries were 84 and 81% for ADI and malic enzyme, respectively, for T. vaginalis SS22; 86% for ADI with
SS22-MOZ2; 93% for ADI with MOZ2.
Table 3. Intracellular and extracellular concentrations of amines in the parent uninfected T. vaginalis strain SS22 and T. vaginalis
infected with M. hominis (SS22-MOZ2)
The concentration of amines was determined by HPLC as described in Methods.
Amine T. vaginalis SS22 T. vaginalis SS22-MOZ2
Intracellular concentration
(mM per 10
6 cells)
Extracellular concentration
(mM)
Intracellular concentration
(mM per 10
6 cells)
Extracellular concentration
(mM)
Arginine 0.51 5.63 0.46 2.31
Citrulline 0.12 0.15 0.06 0.04
Ornithine 0.03 0.06 0.45 0.31
Putrescine 0.19 1.92 0.43 5.32
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in ornithine and putrescine production. M. hominis has a
minimal genome that lacks an ODC gene (Pereyre et al.,
2009) and ODC enzyme activity (this study); hence, it is
likely that theornithine produced byM. hominis is exported,
possibly via an arginine/ornithine transporter, as demon-
strated in other prokaryotes that contain the ADH pathway
(Driessen et al., 1987). M. hominis has a number of
transporters that are capable of satisfying its nutritional
requirement for several amino acids (Pereyre et al., 2009). In
particular, MHO_5040 is proposed to encode a functional
M. hominis arginine permease (Pereyre et al., 2009). The
rapid removal of arginine from the cytoplasm of T. vaginalis
by M. hominis and its replacement by exported ornithine
via a putative arginine/ornithine transporter would result in
an increased cytoplasmic ornithine concentration, which
could then drive increased putrescine formation by the T.
vaginalis ODC. Thus, this relationship would provide M.
hominis with a constant supply of putrescine, which it is
incapable of synthesizing. The benefit of this symbiotic
relationship to T. vaginalis is not so clear; however, the
increased scavenging of arginine may be significant, since it
would reduce the amount of free arginine available for nitric
oxide (NO) production by host macrophages. T. vaginalis
has a flavorubredoxin-like-dependent NO reductase with a
reported Km of 1.2 mM, which would effectively remove NO
(Sarti et al., 2004). However, the concentration of arginine
in vaginal fluid has been reported to be 210 mM (Chen et al.,
1982), which is reduced to undetectable levels during
infection; hence, the combined arginine sink in T. vaginalis
infected with M. hominis would effectively reduce free
arginine concentrations to levels below the Km of the host
NO synthase. Depletion of arginine by ADI could therefore
block NO production by macrophages and thereby block an
important host defence mechanism (Dillon et al., 2002). A
role for M. hominis ADI in suppression of NO production
caused by macrophage-inducible NO synthase has been
proposed (Noh et al., 2002). It has been proposed that G.
intestinalis releases ADI in contact with host epithelial cells,
which protects it from host NO production (Ringqvist et al.,
2008). The G. intestinalis ADI has also been implicated in
multiple functions, including antigenic switching and
migration to the nucleus, where it has a regulatory role in
gene expression during encystation (Touz et al., 2008). In T.
vaginalis, however, ADI localizes predominantly to the
hydrogenosomal fraction.
We have previously demonstrated that ADI is the step with
the lowest velocity and is therefore proposed to be the rate-
limiting step of the pathway (Yarlett et al., 1996). However,
the actual change in flow through the pathway caused by
the presence of M. hominis is more complex than this, and
is best described by determination of the flux control
coefficients and elasticity of the enzymes involved (Fell,
1997). Based on the kinetic data for the ADH enzymes and
knowing the intracellular concentrations of the intermedi-
ates, the elasticity of each enzyme of the pathway can be
determined (Table 2). From this it can be shown that the
increase in ornithine has a significant effect upon the flux
control of the pathway (C
J
ODC increases from 1/25 to 1/10).
Based upon the data obtained in this study we propose that
the additional ornithine present in the T. vaginalis cytosol
is derived from M. hominis. Ornithine drives the formation
of putrescine via a T. vaginalis ODC and can also be a
substrate for the T. vaginalis lysine/ornithine aminotrans-
ferase (OAT; EC 2.6.1.13; TVAG 258770; Carlton et al.,
2007), resulting in the formation of glutamate and
D-pyrroline 5-carboxylate (Lowe & Rowe, 1986; Carlton
et al., 2007). Glutamate, in turn, could drive the formation
of cytosolic alanine by alanine aminotransferase (EC
2.6.1.2; Lowe & Rowe, 1986). Multiple copies of the
alanine aminotransferase gene have been identified in the
T. vaginalis genome (Carlton et al., 2007); based upon the
presence of a hydrogenosomal targeting sequence, these
genes encode alanine aminotransferases that localize to
both the hydrogenosome and the cytosol (Carlton et al.,
2007). The cytosolic alanine can enter the hydrogenosome,
resulting in the production of hydrogenosomal pyruvate,
and could therefore act as an alanine/pyruvate shuttle for
provision of hydrogenosomal pyruvate and be involved in
ATP generation by the T. vaginalis pyruvate:ferredoxin
oxidoreductase-coupled succinate thiokinase pathway. We
conclude that the association of M. hominis with T.
vaginalis is an example of a mutually beneficial endosym-
biotic relationship.
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